Human Testing on HIV Vaccine

Trials could begin as early as January

Will an HIV vaccine become a reality? (photo by Think Stock)

Besides a cure, the two words we’ve been wanting to hear for the past 30 years? HIV vaccine. According to recent news reports, the U.S. Food and Drug Administration got the go ahead to begin human trials on a potential HIV vaccine that’s been studied since 1987.

According to the National Post, a virologist in Canada at the University of Western Ontario will be leading the research team next month. If successful, the vaccine could be marketed in America within the next few years.

The vaccine could work by injecting dead HIV virus into infected cells, says the report. For the first human study, as many as 40 patients will be tested. If successful, the test would then study at least 600 HIV-negative people considered high-risk for the disease. The third phase would include as many as 6,000 negative people to find out if the vaccine prevents them from acquiring HIV.

Would you be willing to take part in human trials? And if a vaccine is discovered, how do you expect that will change our lives?